MCM
KRTX

Manchester Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Manchester Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$317 – 1077
2023
Q4 		$317 Hold
1
– – ﹤0.01% 950
2023
Q3 		$170 Hold
1
– – ﹤0.01% 968
2023
Q2 		$217 Buy
+1
New +$214 ﹤0.01% 925

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Manchester Capital Management's KRTX Position: Q1 2024 in Review

Manchester Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1 share — an estimated $317 sold.

Manchester Capital Management first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $317 in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Manchester Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Manchester Capital Management sold 1 Karuna Therapeutics, Inc. Common Stock share in Q1 2024, an estimated $317.
  • Manchester Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
  • Manchester Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $317 in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Manchester Capital Management's 13F filing for Q1 2024, filed 6 May 2024.